Engineers Gate Manager’s UroGen Pharma URGN Stock Holding History

Engineers Gate Manager’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$603K	Buy	+16,378	New	+$444K	0.01%	1389
2025 Q2	–	Sell	-20,327	Closed	-$225K	–	2560
2025 Q1	$225K	Buy	20,327 +2,209	+12%	+$23.6K	﹤0.01%	1839
2024 Q4	$193K	Sell	18,118 -2,022	-10%	-$24.2K	﹤0.01%	1892
2024 Q3	$256K	Buy	20,140 +7,395	+58%	+$110K	0.01%	1685
2024 Q2	$214K	Buy	12,745 +109	+0.9%	+$1.55K	﹤0.01%	1622
2024 Q1	$190K	Sell	12,636 -974	-7%	-$15.9K	0.01%	1656
2023 Q4	$204K	Buy	+13,610	New	+$177K	0.01%	1633

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Engineers Gate Manager's URGN Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in UroGen Pharma (URGN) in Q2 2026: 16,378 shares worth $603K. The stake represents 0.01% of the portfolio and ranks #1389 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in URGN as recently as Q1 2025.

Engineers Gate Manager first reported a position in URGN in Q4 2023 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

Engineers Gate Manager held 16,378 shares of UroGen Pharma worth $603K as of Q2 2026.
UroGen Pharma was a new Engineers Gate Manager position in Q2 2026.
UroGen Pharma made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1389 holding.
Engineers Gate Manager first reported a position in UroGen Pharma in Q4 2023 and has held it in 7 quarters since.
190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.